NEUARTIGE EGFR-VARIANTE
European patent · EP2956554 · Deleted
Register entry
- Publication number
- EP2956554
- Application number
- EP14751442
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 14, 2014
- Published
- Dec 23, 2015
- Granted
- Oct 9, 2019
- Deleted
- Feb 29, 2020
- Reason
- Annual fee unpaid
- IPC classes
- C12Q 1/6886 (2018.01)C07K 14/71 (2006.01)G01N 33/574 (2006.01)C07K 16/28 (2006.01)C07K 14/485 (2006.01)C12N 15/113 (2010.01)
- Priority
- US 201361765537 P 15.02.2013
- PCT application
- PCT/US2014/016536 14.02.2014
- PCT publication
- WO2014/127266 21.08.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2020
Deleted, fee unpaid
Published in Swissreg on 23.09.2020
- Feb 12, 2020
Owner
- Owner
- Exosome Diagnostics Inc., The Lasker Biomedical Research Building, 3960 Broadway, Suite 540, New York, NY 10032, USA → Exosome Diagnostics, Inc., 266 Second Avenue, Suite 200, Waltham, MA 02451, USA
Published in Swissreg on 12.02.2020
- Oct 9, 2019
Granted
Published in Swissreg on 09.10.2019
Parties
Inventor
SKOG, Johan, Karl, Olov
Charlestown, MA 02129, US
BERGHOFF, Emily
Cambridge, MA 02139, US
LOGUIDICE, Lori
Cambridge, MA 02139, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.